Cassels represented Ramm Pharma. On December 30, 2020, Ramm Pharma Corp., a leader in plant-derived cannabinoid (CBD) pharmaceutical and other cannabis-based products, completed its acquisition of…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
